Semaglutide and Warfarin: What to Know About INR

If you take warfarin, starting semaglutide deserves a conversation with your anticoagulation clinic. Controlled interaction studies are reassuring, but they do not establish that your INR will stay unchanged. Warfarin's effect can change with illness, nutrition and other medicines, even without a direct interaction between the two drug molecules.

INR is the blood test used to guide warfarin treatment. Your target and testing schedule depend on why you take the anticoagulant and your clinical situation. Warfarin labeling requires regular monitoring and additional attention when medicines change.¹ There is no universal instruction to reduce warfarin when semaglutide starts.

What the injection study actually tested

A 2017 study examined a single 25 mg warfarin dose before and during steady-state semaglutide 1 mg injected weekly in healthy volunteers. The warfarin pharmacokinetic analysis included 22 participants. Researchers assessed warfarin exposure, peak concentrations and INR responses, finding no clinically relevant interaction under those conditions.²

That was not a trial of people taking long-term warfarin for atrial fibrillation, a mechanical heart valve or a previous blood clot. It did not test every current semaglutide dose. The study's single warfarin dose is a research detail, not a suggested dose for readers.

The oral study was a different experiment

A separate study's first trial enrolled 52 healthy volunteers and tested single-dose warfarin 25 mg with oral semaglutide 20 mg daily at steady state, as well as an absorption-enhancer-only condition. Semaglutide did not produce an apparent clinically important change in warfarin exposure or the measured INR response.³

The 20 mg regimen was investigational. It should not be read as a currently prescribed tablet strength or used to construct a dosing schedule. Both studies help answer a controlled absorption question; neither promises stable anticoagulation during vomiting, major dietary change or another illness. They also cannot be transferred without qualification to every formulation and dose.

Why monitoring still matters

Current oral semaglutide labeling advises increased monitoring for oral medicines with a narrow therapeutic index or requiring clinical monitoring.^4,5 Warfarin is exactly the kind of medicine for which a measured response matters more than a reassuring interaction summary.

Before starting, increasing, stopping or changing semaglutide, give the anticoagulation clinic the product name, route and planned change. Ask whether your next INR should be brought forward and which symptoms or changes require contact. The clinic should choose the interval; there is no evidence-based universal extra-test day for every patient.

Tell them about every new prescription and over-the-counter medicine too. Warfarin labeling specifically calls for closer monitoring when other medicines are started, stopped or changed.¹ An antibiotic or steroid course may matter separately from semaglutide. Our antibiotics guide and ibuprofen guide explain why those additions deserve their own review.

Keep food changes consistent and report illness

Warfarin labeling identifies diarrhea, poor nutritional intake and vitamin K deficiency as factors that can increase INR; increased vitamin K intake can reduce its effect.¹ A sudden diet change while losing weight therefore deserves discussion. Do not eliminate vegetables to avoid vitamin K. Aim for consistency and ask the clinic about major changes in portions, meal replacements or supplements.

What to eat on Wegovy can help with food tolerance, but your anticoagulation plan still governs vitamin K consistency. Report persistent vomiting or diarrhea, missed meals or an inability to keep medicines down. Do not take an extra warfarin tablet after vomiting unless the clinic specifically directs it.

Semaglutide-related gastrointestinal losses can also cause dehydration and kidney injury.⁴ The dehydration guide explains symptoms that need prompt assessment. A change in intake or illness is useful information for the clinic even before you know whether INR has changed.

Timing does not replace INR checks

For semaglutide tablets, follow the morning fasting instructions and wait at least 30 minutes before other oral medicines.^4,5 Ask a pharmacist to reconcile this with your established warfarin schedule; do not move or skip doses casually. The oral morning routine explains the tablet rules. Weekly injections have a different administration routine.

Seek urgent care for serious bleeding, vomiting blood, black or bloody stools, or a significant head injury. Report unusual bruising or persistent bleeding promptly.¹ A previously normal INR is not a reason to ignore new symptoms.